CLINICAL

Abuse-Deterrent Opioid Rexista Makes Misusers Blue—LiterallyHow one opioid abuse deterrent could make it easy to identify misuse.
Safinamide (Xadago): Approved as Add-On for Parkinson’sXadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
FDA Orders Stop Sale of PainkillerThe first opioid taken off the shelves because of potential abuse.
Staff Burnout Rates are High at Pharmacy SchoolsA study found that pharmacy practice faculty experience high rates of emotional exhaustion.
Where Are the New Antibiotics?With the threat of superbugs and the possibility of an antibiotic-less future, alternatives are needed now.
Pharmacy Groups Warn Trump About Drug ImportsNACDS and APhA warn that letting Americans buy foreign drugs could be disastrous.
Cancer Drug Spending SoarsNew therapies and increased awareness lead to a large market.
What You Need to Know about Chronic Care Management
What You Need to Know about Chronic Care ManagementReimbursement, initiation, and what pharmacists can do.
How Pharmacists Can Team Up with Physicians to Improve CareIncreased collaboration with physicians means better health outcomes, but what does that look like in the real world?
DIR Fees: What NCPA Wants from Part DIn a letter to the CMS, DIR fees take precedence

Poll